AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...

Johnson & Johnson (J&J) has announced that it is seeking US Food and Drug Administration (FDA) approval to include new ...

The US Food and Drug Administration (FDA) has approved Apellis Pharmaceuticals’ Sobi-partnered Empaveli (pegcetacoplan) to ...

Proactive protection This trend captures a universal human truth – when the world feels uncertain, we cling to what we can ...

Gilead Sciences’ Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets) has been approved by the ...